Jean Felipe Prodocimo Lestingi
Papers
1
Total Citations
2
H-Index
1
About
Jean Felipe Prodocimo Lestingi is a urologic surgeon and researcher whose work centers on advancing surgical oncology, particularly in prostate cancer management. His primary research areas include robot-assisted radical prostatectomy (RARP), extended pelvic lymph node dissection (ePLND), and the optimization of preoperative risk stratification for lymph node metastases. Lestingi’s major contribution lies in clarifying the indications and technical nuances of ePLND during RARP, a procedure critical for accurate staging and treatment planning in prostate cancer patients. His most-cited paper, “Robot-assisted extended pelvic lymph node dissection in prostate cancer. When and how?” (2019), systematically reviews evidence to guide surgeons on patient selection and surgical technique, addressing a key clinical challenge in balancing oncologic benefit with procedural morbidity. Though early in his citation trajectory, this work has garnered attention for its practical, evidence-based framework. Lestingi’s research bridges the gap between robotic surgical innovation and evidence-based urologic oncology, offering actionable insights for clinicians. His focus on refining surgical protocols and predictive models underscores a commitment to improving outcomes for prostate cancer patients, positioning him as a rising voice in the field of minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1